COMMUNIQUÉS West-GlobeNewswire

Guerbet renforce son expertise avec le lancement de Contrast&Care®, une solution de gestion de l'injection des produits de contraste pour les centres d'imagerie médicale

23/11/2017 - 08:02

Contrast&Care ® vient d'obtenir le marquage CE Contrast&Care sera présenté au RSNA Villepinte (France), le 23 novembre 2017 (8 heures CET) - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de [...]

Saniona AB: Saniona AB's Nomination Committee for the 2018 Annual General Meeting

23/11/2017 - 08:01

PRESS RELEASE November 23, 2017 The Annual General Meeting on May 23, 2017, resolved that a Nomination Committee shall be appointed before coming election and remuneration. The Nomination Committee shall comprise three [...]

THIRD GLOBAL IRON DEFICIENCY DAY TO RAISE AWARENESS OF THE SYMPTOMS OF IRON DEFICIENCY

23/11/2017 - 07:01

Iron Deficiency Day takes place annually on 26 November to highlight the impact of iron deficiency, an under-recognised and underdiagnosed condition even in up-to-date healthcare systems. 1,2 This year's Iron Deficiency [...]

Probiodrug : Probiodrug AG to Publish its Third Quarter 2017 Business Update on 30 November 2017

23/11/2017 - 07:00

Probiodrug AG to Publish its Third Quarter 2017 Business Update on 30 November 2017 HALLE (SAALE), Germany, 23 November 2017 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel [...]

IGC Announces Adjournment of Annual Meeting Voting for Proposals Three and Four to Dec 15, 2017

22/11/2017 - 23:00

BETHESDA, Md., Nov. 22, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC), adjourned again the voting for Proposals Three and Four from its Notice of Annual Meeting of Shareholders, dated [...]

Forward Pharma Announces Completion of Corporate Restructuring Plan

22/11/2017 - 22:30

COPENHAGEN, Denmark, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ: FWP ) (“Forward Pharma”) today announced the completion of its previously announced corporate restructuring plan (the “Restructuring”) [...]

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

22/11/2017 - 22:30

BRIDGEWATER, N.J., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced the granting of [...]

RedHawk Announces First Quarter Results

22/11/2017 - 22:30

LAFAYETTE, La., Nov. 22, 2017 (GLOBE NEWSWIRE) -- RedHawk Holdings Corp. (OTCQB:IDNG) (“RedHawk” or the “Company”) announced today its results for the three-month period ended September 30, 2017 as it continues to [...]

Cannevert Scientists to Present Their First Peer-Reviewed Research at December’s Prestigious British Pharmacological Society Meeting in London, UK

22/11/2017 - 22:15

VANCOUVER, British Columbia, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ), (“Veritas” or the “Company”) announces that the scientists of its research arm, Cannevert [...]

TESARO Announces Participation in Two Investor Conferences

22/11/2017 - 22:05

WALTHAM, Mass., Nov. 22, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences [...]

Prothena to Participate in the Evercore ISI Biopharma Catalyst/Deep Dive Conference

22/11/2017 - 22:05

DUBLIN, Ireland, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ: PRTA ), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in [...]

Adamas to Present at Two Upcoming Investor Conferences

22/11/2017 - 18:42

EMERYVILLE, Calif., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that company management is scheduled to present at two upcoming investor conferences: Richard A. King, [...]

GENFIT: Positive Outcome from the 18-month Pre-Planned Safety Review by the DSMB, in RESOLVE-IT Phase 3 Clinical Trial with elafibranor

22/11/2017 - 18:19

GENFIT: Positive Outcome from the 18-month Pre-Planned Safety Review by the DSMB, in RESOLVE-IT Phase 3 Clinical Trial with elafibranor Safety data, including adverse events and laboratory data, were reviewed by the [...]

GENFIT : issue positive du DSMB suite à la revue planifiée à 18 mois des données de tolérance et de sécurité d'emploi d'elafibranor, dans l'étude clinique de Phase 3 RESOLVE-IT

22/11/2017 - 18:19

GENFIT : issue positive du DSMB suite à la revue planifiée à 18 mois des données de tolérance et de sécurité d'emploi d'elafibranor, dans l'étude clinique de Phase 3 RESOLVE-IT Les données de tolérance et de sécurité d' [...]

Innate Pharma provides an update on Lirilumab

22/11/2017 - 17:46

INNATE PHARMA PROVIDES AN UPDATE ON LIRILUMAB Lirilumab continues to be well-tolerated in monotherapy and in combination across multiple tumor indications in an exploratory clinical program with partner Bristol-Myers [...]

Innate Pharma annonce une mise à jour du programme Lirilumab

22/11/2017 - 17:46

INNATE PHARMA ANNONCE UNE MISE A JOUR DU PROGRAMME LIRILUMAB Dans le programme clinique exploratoire mené par Bristol-Myers Squibb, lirilumab continue d'être bien toléré en monothérapie et en combinaison dans [...]

Sienna Senior Living named one of Canada’s Most Admired Corporate Cultures for 2017

22/11/2017 - 17:44

MARKHAM, Ontario, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Sienna Senior Living (TSX: SIA ) (“ Sienna ”) announced today that it has been named among Canada’s Most Admired Corporate Cultures in the Enterprise category by [...]

Analogic Announces Timing for First Quarter 2018 Earnings Conference Call and Webcast

22/11/2017 - 17:00

PEABODY, Mass., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq: ALOG ) announced today that it will conduct a conference call on Wednesday, December 6, 2017, at 5:00 p.m. (ET) to discuss results for the [...]

Axim Biotechnologies Reports Third Quarter 2017 Results

22/11/2017 - 16:00

NEW YORK, Nov. 22, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced results for the quarter ended September 30, [...]